138 research outputs found
Asymmetrische Übergangsmetallkatalyse mit Kohlenhydratliganden
Im Rahmen dieser Arbeit wurden verschiedene kohlenhydratbasierte Ligandensysteme konzipiert und synthetisiert. So konnten unter anderem mehrere Triazol- und Oxazolin-basierte N-Donorliganden entwickelt werden und diese in asymmetrischen C-C-Bindungsknüpfungsreaktionen erfolgreich eingesetzt werden. In der Arbeit wird auf die Synthese der Liganden und deren Anwendung in asymmetrischen Reaktionen näher eingegangen. Zusätzlich werden Vorschläge für den Ursprung der beobachteten Enantioselektivität erörtert
Recommended from our members
Optical band gap of cross-linked, curved, and radical polyaromatic hydrocarbons.
In this work, the optical band gaps of polycyclic aromatic hydrocarbons (PAHs) crosslinked via an aliphatic bond, curved via pentagon integration and with radical character were computed using density functional theory. A variety of different functionals were benchmarked against optical band gaps (OBGs) measured by ultraviolet-visible spectroscopy with HSE06 being most accurate with a percentage error of 6% for a moderate basis set. Pericondensed aromatics with different symmetries were calculated with this improved functional providing new scaling relationships for the OBG versus size. Further calculations showed crosslinks cause a small decrease in the OBG of the monomers which saturates after 3-4 crosslinks. Curvature in PAHs was shown to increase the optical band gap due to the resulting change in hybridisation of the system, but this increase saturated at larger sizes. The increase in OBG between a flat PAH and a strained curved one was shown to be equivalent to a difference of several rings in size for pericondensed aromatic systems. The effect of σ-radicals on the optical band gap was also shown to be negligible, however, π-radicals were found to decrease the band gap by ∼0.5 eV. These findings have applications in understanding the molecular species involved in soot formation
Recommended from our members
Improved methodology for performing the inverse Abel transform of flame images for color ratio pyrometry.
A new method is presented for performing the Abel inversion by fitting the line-of-sight projection of a predefined intensity distribution (FLiPPID) to the recorded 2D projections. The aim is to develop a methodology that is less prone to experimental noise when analyzing the projection of axisymmetric objects-in this case, co-flow diffusion flame images for color ratio pyrometry. A regression model is chosen for the light emission intensity distribution of the flame cross section as a function of radial distance from the flame center line. The forward Abel transform of this model function is fitted to the projected light intensity recorded by a color camera. For each of the three color channels, the model function requires three fitting parameters to match the radial intensity profile at each height above the burner. This results in a very smooth Abel inversion with no artifacts such as oscillations or negative values of the light source intensity, as is commonly observed for alternative Abel inversion techniques, such as the basis-set expansion or onion peeling. The advantages of the new FLiPPID method are illustrated by calculating the soot temperature and volume fraction profiles inside a co-flow diffusion flame, both being significantly smoother than those produced by the alternative inversion methods. The developed FLiPPID methodology can be applied to numerous other optical techniques for which smooth inverse Abel transforms are required
Recommended from our members
Polymorphism of nanocrystalline TiO2 prepared in a stagnation flame: formation of the TiO2-II phase.
A metastable "high-pressure" phase known as α-PbO2-type TiO2 or TiO2-II is prepared via a single-step synthesis using a laminar premixed stagnation flame. Three other TiO2 polymorphs, namely anatase, rutile and TiO2-B phases, can also be obtained by tuning the oxygen/fuel ratio. TiO2-II is observed as a mixture with rutile under oxygen-lean flame conditions. To the best of our knowledge, this is the first time that this phase has been identified in flame-synthesised TiO2. The formation of TiO2-II in an atmospheric pressure flame cannot be explained thermodynamically and is hypothesised to be kinetically driven through the oxidation and solid-state transformation of a sub-oxide TiO2-x intermediate. In this scenario, rutile is nucleated from the metastable TiO2-II phase instead of directly from a molten/amorphous state. Mixtures containing three-phase heterojunctions of anatase, rutile, and TiO2-II nanoparticles as prepared here in slightly oxygen-lean flames might be important in photocatalysis due to enhanced electron-hole separation
Evolution of mechanical response and dislocation microstructures in small-scale specimens under slightly different loading conditions
Phosphorylation-dependent differences in CXCR4-LASP1-AKT1 Interaction between breast cancer and chronic myeloid leukemia
The serine/threonine protein kinase AKT1 is a downstream target of the chemokine receptor4 (CXCR4), and both proteins play a central role in the modulation of diverse cellular processes,including proliferation and cell survival. While in chronic myeloid leukemia (CML) the CXCR4is downregulated, thereby promoting the mobilization of progenitor cells into blood, the receptoris highly expressed in breast cancer cells, favoring the migratory capacity of these cells. Recently,the LIM and SH3 domain protein 1 (LASP1) has been described as a novel CXCR4 binding partnerand as a promoter of the PI3K/AKT pathway. In this study, we uncovered a direct binding ofLASP1, phosphorylated at S146, to both CXCR4 and AKT1, as shown by immunoprecipitation assays,pull-down experiments, and immunohistochemistry data. In contrast, phosphorylation of LASP1at Y171 abrogated these interactions, suggesting that both LASP1 phospho-forms interact. Finally,findings demonstrating different phosphorylation patterns of LASP1 in breast cancer and chronicmyeloid leukemia may have implications for CXCR4 function and tyrosine kinase inhibitor treatment
- …